News

Efficacy of Hyaluronic Acid Eye Drops in the Treatment of Dry Eye Syndrome –⁠ Results of a Meta-Analysis

13. 3. 2023 Source: Ophthalmologic Diseases

Dry eye syndrome affects 5–30% of individuals over the age of 50. The beneficial effect of hyaluronic acid on the symptoms of this condition has been well described in both preclinical and clinical studies, and it has been shown that its topical application increases the secretion of water and mucin on the surface of the eye. The meta-analysis presented below focused on the efficacy of eye drops containing hyaluronic acid in the treatment of dry eye syndrome.

Prof. Petra Lišková: Prevention of Dry Eye Syndrome is Difficult but Not Impossible

Dry eye syndrome is one of the most common ophthalmological problems, and its incidence is rising. Ophthalmologist Prof. MUDr. Petra Lišková, Ph.D., from the Clinic of Pediatrics and Hereditary…

13. 3. 2023 Source: Ophthalmologic Diseases

Development and Benefits of Intestinal Gel LECIG for Patients with Parkinson's Disease

Patients with advanced Parkinson's disease, for whom the current regimen of orally and transdermally administered medications is insufficient for symptom relief, now have a new treatment option. It…

10. 3. 2023 Source: Parkinson's Disease

Intestinal Gel LECIG in the Treatment of Advanced Parkinson's Disease in Real Practice

A recently published study presents the first experiences with an intestinal gel containing a triple combination of antiparkinsonian drugs and dosed via an infusion pump through percutaneous…

10. 3. 2023 Source: Parkinson's Disease

Doc. Jiří Kubeš: The major benefit of proton therapy lies in protecting healthy tissues

Nearly 9,000 patients with oncological diseases have already undergone modern proton radiotherapy at the Proton Center in Prague. Which diagnoses are suitable for this treatment modality, what are…

7. 3. 2023 Source: Proton Radiotherapy

Intestinal Infection of Multi-Resistant NDM-Producing K. pneumoniae in a Patient with NK/T Lymphoma –⁠ Case Study

The incidence of NDM-producing Klebsiella pneumoniae is increasing worldwide. NDM beta-lactamase is a significant cause of multidrug resistance in enterobacteria to various antibiotics, including…

3. 3. 2023 Source: Anti-Infectives

Invitation to ZEPOSIA STAND ALONE MEETING

On behalf of Bristol Myers Squibb, we warmly invite you to the Zeposia Stand Alone Meeting, which will take place on March 22, 2023, at 5 PM at the EA Hotel Tereziánský dvůr in Hradec Králové.

2. 3. 2023 Source: Modulation of S1P in the Treatment of Autoimmune Diseases

Targeted Treatment of Children and Adolescents with Severe AD –⁠ Case Studies

The results of therapy with dupilumab in children and adolescents with severe forms of atopic dermatitis (AD) are very good even after a short period, not only from a health perspective but also in terms...

2. 3. 2023 Source: Systemic treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis – Type 2 inflammation

Carpal Tunnel Syndrome as a Warning Sign of Cardiomyopathy Caused by Transthyretin Amyloidosis

Recent study results suggest that transthyretin amyloidosis is a more common cause of heart failure than previously thought. Early diagnosis and subsequent therapy are key to improving patient…

2. 3. 2023 Source: Amyloidosis

INFOGRAPHIC: Diagnostic Algorithm for Cardiac Amyloidosis

What examinations are needed when cardiac amyloidosis is suspected? Which tests can distinguish transthyretin amyloidosis from systemic disease caused by immunoglobulin light chains? We bring you a…

27. 2. 2023 Source: Amyloidosis

Current Position of Venetoclax in the Treatment of AML −⁠ Hope for a Better Prognosis?

The treatment of acute myeloid leukemia (AML) remained stagnant for a long time, with many new drugs emerging only in the past few years. One of the newest and most important is the Bcl-2…

27. 2. 2023 Source: Acute Myeloid Leukemia

Venetostart –⁠ The First Comprehensive Mobile Application with Practical Information for Venetoclax Treatment

Abbvie has developed the comprehensive mobile application Venetostart with practical information needed in clinical practice for administering venetoclax (Venclyxto), which is indicated for the…

27. 2. 2023 Source: Chronic Lymphocytic Leukemia

INFOGRAPHIC: Which treatment to choose in the 1st line for a patient with type 2 diabetes?

Diabetes mellitus is a complex chronic disease that requires continuous treatment and a strategy to reduce associated risks beyond mere glycemic control. Comorbidities and the risk of complications are...

24. 2. 2023 Source: Diabetes

Is exposure to mite allergens in breast milk or house dust a risk factor for asthma and allergies in childhood?

Exposure to mite allergens occurs early in life from both breast milk and house dust (especially bedding). The study presented below examined the impact of exposure to the dominant mite allergen Der p...

23. 2. 2023 Source: Dust Mite Allergy

Sonicare Technology as a Modern Means for Good Oral Hygiene

Sonicare technology was developed and introduced to the market by Philips 30 years ago. Since then, the range of products has expanded, and the use of sonic technology has become accessible to a wide…

23. 2. 2023 Source: Dental Care

1 … 34 35 36 37 38 … 115

Back Filter by speciality

Remove filters

Popular this week